{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:41:20Z","timestamp":1782891680491,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of insomnia in patients with myasthenia gravis (MG) poses a clinical challenge, as MG is a well-recognized contraindication to sedative-hypnotic agents. This retrospective study aimed to assess the efficacy and safety of low-dose trazodone hydrochloride for the management of insomnia in MG patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were collected from MG patients with comorbid insomnia who received low-dose trazodone hydrochloride (25\u2013100\u00a0mg, once nightly, for \u2265\u20094 weeks). Enrolled patients were stratified into three groups based on Self-Rating Depression Scale (SDS) scores: pure insomnia group (SDS: 0\u201352), mild depression group (SDS: 53\u201362), and moderate-to-severe depression group (SDS\u2009\u2265\u200963). Changes in Pittsburgh Sleep Quality Index (PSQI) scores, SDS scores, and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores before and after trazodone hydrochloride administration were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Total 68 MG patients were enrolled, including 17 cases of ocular MG and 51 cases of mild generalized MG. Of these patients, 18 (26.5%) were assigned to the pure insomnia group, 30 (44.1%) to the mild depression group, and 20 (29.4%) to the moderate-to-severe depression group. Post-treatment PSQI scores were significantly reduced compared to baseline across all groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). The mild depression group exhibited a significant decrease in SDS scores after treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), whereas no significant reduction in SDS scores was observed in the moderate-to-severe depression group. No patients experienced an increase in MG-ADL scores. Mild adverse events were reported in 4 patients (5.9%), including hypotension (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092), dizziness (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), and nausea (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low-dose trazodone hydrochloride demonstrates favorable efficacy and safety in improving insomnia in patients with stable and mild MG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04962-x","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:25:27Z","timestamp":1778239527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of low-dose trazodone hydrochloride for insomnia in patients with myasthenia gravis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jing-ting","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-yun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-qiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-6822","authenticated-orcid":false,"given":"Shi-lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"4962_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3760\/cma.j.cn113694-20250120-00041","volume":"58","author":"Chinese Society of Neuroimmunology","year":"2025","unstructured":"Chinese Society of Neuroimmunology. Chinese guideline for diagnosis and treatment of mysthennia gravis (2025 edition). Chin J Neurol. 2025;58:721\u201341. https:\/\/doi.org\/10.3760\/cma.j.cn113694-20250120-00041.","journal-title":"Chin J Neurol"},{"key":"4962_CR2","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1007\/s00415-021-10902-1","volume":"269","author":"LK Andersen","year":"2022","unstructured":"Andersen LK, Jakobsson AS, Revsbech KL, Vissing J. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis. J Neurol. 2022;269:3086\u201393. https:\/\/doi.org\/10.1007\/s00415-021-10902-1.","journal-title":"J Neurol"},{"key":"4962_CR3","doi-asserted-by":"publisher","first-page":"e00538","DOI":"10.1002\/brb3.538","volume":"6","author":"S Hoffmann","year":"2016","unstructured":"Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A. Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain Behav. 2016;6:e00538. https:\/\/doi.org\/10.1002\/brb3.538.","journal-title":"Brain Behav"},{"key":"4962_CR4","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00415-018-8995-4","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva TM, Gavrilov YV, Kreis OA, Valko PO, Weber KP, Valko Y. Fatigue in patients with myasthenia gravis. J Neurol. 2018;265:2312\u201321. https:\/\/doi.org\/10.1007\/s00415-018-8995-4.","journal-title":"J Neurol"},{"key":"4962_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2018.01.011","volume":"50","author":"NFT Braz","year":"2018","unstructured":"Braz NFT, Rocha NP, Vieira \u00c9LM, Barbosa IG, Gomez RS, Kakehasi AM, Teixeira AL. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis. J Clin Neurosci. 2018;50:41\u20134. https:\/\/doi.org\/10.1016\/j.jocn.2018.01.011.","journal-title":"J Clin Neurosci"},{"key":"4962_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4274\/npa.y5611","volume":"50","author":"F Aysal","year":"2013","unstructured":"Aysal F, Karamustafalio\u011flu O, \u00d6z\u00e7elik B, Yilmaz M, Karamustafalio\u011flu N, Yumruk\u00e7al H, Tankaya O. The relationship of symptoms of anxiety and depression with disease severity and treatment modality in myasthenia gravis: a cross-sectional study. Noro Psikiyatr Ars. 2013;50:295\u2013300. https:\/\/doi.org\/10.4274\/npa.y5611.","journal-title":"Noro Psikiyatr Ars"},{"key":"4962_CR7","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00415-020-09767-7","volume":"267","author":"YV Gavrilov","year":"2020","unstructured":"Gavrilov YV, Alekseeva TM, Kreis OA, Valko PO, Weber KP, Valko Y. Depression in myasthenia gravis: a heterogeneous and intriguing entity. J Neurol. 2020;267:1802\u201311. https:\/\/doi.org\/10.1007\/s00415-020-09767-7.","journal-title":"J Neurol"},{"key":"4962_CR8","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3760\/cma.j.issn.0376-2491.2010.45.004","volume":"90","author":"L Qiu","year":"2010","unstructured":"Qiu L, Feng HY, Huang X, Mo R, Ou CY, Luo CM, Li Y, Liu WB. Study of incidence and correlation factors of depression, anxiety and insomnia in patients with myasthenia gravis. Natl Med J China. 2010;90:3176\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2010.45.004.","journal-title":"Natl Med J China"},{"key":"4962_CR9","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.16766\/j.cnki.issn.1674-4152.001062","volume":"17","author":"XN Wang","year":"2019","unstructured":"Wang XN, Yuan YQ, Ren TT, Zhang M, Zhu XY, Wang HR, Fan SH. Sleep quality and comtributory factors in myasthenia gravis patients. Chin J Gen Pract. 2019;17:1812\u20135. https:\/\/doi.org\/10.16766\/j.cnki.issn.1674-4152.001062.","journal-title":"Chin J Gen Pract"},{"key":"4962_CR10","doi-asserted-by":"publisher","unstructured":"Li Ning. The clinical study of sleep disorder in patients with myasthenia gravis. Dissertation, China Medical University. 2023. https:\/\/doi.org\/10.27652\/d.cnki.gzyku.2022.000556.","DOI":"10.27652\/d.cnki.gzyku.2022.000556"},{"key":"4962_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1176\/appi.neuropsych.18120383","volume":"31","author":"H Jordan","year":"2019","unstructured":"Jordan H, Ortiz N. Management of Insomnia and Anxiety in myasthenia gravis. J Neuropsychiatry Clin Neurosci. 2019;31:386\u201391. https:\/\/doi.org\/10.1176\/appi.neuropsych.18120383.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4962_CR12","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3760\/cma.j.cn112137-20250421-00981","volume":"105","author":"Chinese Sleep Research Society","year":"2025","unstructured":"Chinese Sleep Research Society. Guidelines for the diagnosis and treatment of insomnia disorder (2025 edition). Natl Med J China. 2025;105:2960\u201381. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20250421-00981.","journal-title":"Natl Med J China"},{"key":"4962_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.sleep.2020.08.008","volume":"75","author":"J Kalita","year":"2020","unstructured":"Kalita J, Dongre N, Misra UK. Myasthenic crisis due to anxiety and insomnia during COVID\u2009\u2013\u200919 pandemic. Sleep Med. 2020;75:532\u20133. https:\/\/doi.org\/10.1016\/j.sleep.2020.08.008.","journal-title":"Sleep Med"},{"key":"4962_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.sleep.2020.12.031","volume":"79","author":"J Kalita","year":"2021","unstructured":"Kalita J, Dongre N, Misra UK. Insomnia matters in myasthenia gravis. Sleep Med. 2021;79:221\u20132. https:\/\/doi.org\/10.1016\/j.sleep.2020.12.031.","journal-title":"Sleep Med"},{"key":"4962_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3760\/cma.j.cn113694-20190701-00398","volume":"53","author":"Chinese Society of Neurology, Chinese Society of Sleep Disorders, Chinese Society of Neuropsychology and Behavioral Neurology","year":"2020","unstructured":"Chinese Society of Neurology, Chinese Society of Sleep Disorders, Chinese Society of Neuropsychology and Behavioral Neurology. Expert Consensus on the diagnosis and treatment of insomnia with depression and anxiety in Chinese adults. Chin J Neurol. 2020;53:564\u201374. https:\/\/doi.org\/10.3760\/cma.j.cn113694-20190701-00398.","journal-title":"Chin J Neurol"},{"key":"4962_CR16","doi-asserted-by":"publisher","first-page":"1266862","DOI":"10.3389\/fneur.2023.1266862","volume":"22","author":"JW Yan","year":"2023","unstructured":"Yan JW, Yang MH, Li MK, Huang Y, Tan Y, Shi J, Fan Q, Zhu Z, Guan Y, Cui L. Treatment of insomnia in myasthenia gravis-A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia. Front Neurol. 2023;22:14: 1266862. https:\/\/doi.org\/10.3389\/fneur.2023.1266862.","journal-title":"Front Neurol"},{"key":"4962_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4.","journal-title":"Psychiatry Res"},{"key":"4962_CR18","first-page":"103","volume":"29","author":"XC Liu","year":"1996","unstructured":"Liu XC, Tang MQ, Hu L, Wang AJ, Wu HX, Zhao GF, Gao CN, Li WS. Reliability and validity of the Pittsburgh Sleep Quality Index. Chin J Psychiatry. 1996;29:103\u20137.","journal-title":"Chin J Psychiatry"},{"key":"4962_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"WW Zung","year":"1965","unstructured":"Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63\u201370. https:\/\/doi.org\/10.1001\/archpsyc.1965.01720310065008.","journal-title":"Arch Gen Psychiatry"},{"key":"4962_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3760\/cma.j.cn371468-20220921-00563","volume":"32","author":"Chinese Society of Behavioral Medicine, Cognitive Coping Therapy Group, Chinese Society of Behavioral Medicine","year":"2023","unstructured":"Chinese Society of Behavioral Medicine, Cognitive Coping Therapy Group, Chinese Society of Behavioral Medicine. Expert recommendations on the treatment and management of major depressive disorder. Chin J Behav Brain Sci. 2023;32:193\u2013202. https:\/\/doi.org\/10.3760\/cma.j.cn371468-20220921-00563.","journal-title":"Chin J Behav Brain Sci"},{"key":"4962_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/wnl.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology. 1999;52:1487\u20139. https:\/\/doi.org\/10.1212\/wnl.52.7.1487.","journal-title":"Neurology"},{"key":"4962_CR22","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.13241\/j.cnki.pmb.2015.20.037","volume":"15","author":"S Ma","year":"2015","unstructured":"Ma S, Fan LL, Li HZ, Zhang M, Yang YX, Wang SY, Guo P, Li C, Li ZY. Analysis of sleep quality in 321 myasthenia gravis patients. Progress Mod Biomed. 2015;15:3933\u20136. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2015.20.037.","journal-title":"Progress Mod Biomed"},{"key":"4962_CR23","doi-asserted-by":"publisher","unstructured":"Cui MM. Analysis of incidence rate of sleep disorders and factors associated with sleep quality in first-diagnosed myasthenia gravis patients. Dissertation, China Medical University. 2023. https:\/\/doi.org\/10.27652\/d.cnki.gzyku.2022.000602.","DOI":"10.27652\/d.cnki.gzyku.2022.000602"},{"key":"4962_CR24","doi-asserted-by":"publisher","first-page":"960962","DOI":"10.1007\/s00115-005-1877-x","volume":"76","author":"R Feldmann","year":"2005","unstructured":"Feldmann R, Kiefer R, Wiegard U, Evers S, Weglage J, Intelligenz. Aufmerksamkeit und Ged\u00e4chtnis bei Patienten mit Myasthenia gravis. Intelligence, attention, and memory in patients with myasthenia gravis. Nervenarzt. 2005;76:960962\u2013966. https:\/\/doi.org\/10.1007\/s00115-005-1877-x.","journal-title":"Nervenarzt"},{"key":"4962_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/mus.23941","volume":"48","author":"CD Kassardjian","year":"2013","unstructured":"Kassardjian CD, Murray BJ, Kokokyi S, Jewell D, Barnett C, Bril V, Katzberg HD. Effects of napping on neuromuscular fatigue in myasthenia gravis. Muscle Nerve. 2013;48:816\u20138. https:\/\/doi.org\/10.1002\/mus.23941.","journal-title":"Muscle Nerve"},{"key":"4962_CR26","doi-asserted-by":"publisher","first-page":"E345","DOI":"10.1503\/jpn.220202","volume":"48","author":"G Yu","year":"2023","unstructured":"Yu G, Liu Z, Wu X, Becker B, Zhang K, Fan H, Peng S, Kuang N, Kang J, Dong G, Zhao XM, Schumann G, Feng J, Sahakian BJ, Robbins TW, Palaniyappan L, Zhang J. Common and disorder-specific cortical thickness alterations in internalizing, externalizing and thought disorders during early adolescence: an adolescent brain and cognitive development study. J Psychiatry Neurosci. 2023;48:E345\u201356. https:\/\/doi.org\/10.1503\/jpn.220202.","journal-title":"J Psychiatry Neurosci"},{"key":"4962_CR27","doi-asserted-by":"publisher","unstructured":"Wu X, Zhang K, Kuang N, Kong X, Cao M, Lian Z, Liu Y, Fan H, Yu G, Liu Z, Cheng W, Jia T, Sahakian BJ, Robbins TW, Feng J, Schumann G, Palaniyappan L, Zhang J. Developing brain asymmetry shapes cognitive and psychiatric outcomes in adolescence. Nat Commun. 2025;16:4480. https:\/\/doi.org\/10.1038\/s41467-025-59110-9. Erratum in: Nat Commun. 2025; 16: 6325. http:\/\/doi.org\/10.1038\/s41467-025-61785-z.","DOI":"10.1038\/s41467-025-59110-9"},{"key":"4962_CR28","doi-asserted-by":"publisher","first-page":"21cr02925","DOI":"10.4088\/PCC.21cr02925","volume":"24","author":"R Benjelloun","year":"2022","unstructured":"Benjelloun R, Aasfara J, Otheman Y. Management of acute insomnia and anxiety in a patient with myasthenia gravis and respiratory failure. Prim Care Companion CNS Disord. 2022;24:21cr02925. https:\/\/doi.org\/10.4088\/PCC.21cr02925.","journal-title":"Prim Care Companion CNS Disord"},{"key":"4962_CR29","doi-asserted-by":"publisher","first-page":"116503","DOI":"10.1016\/j.psychres.2025.116503","volume":"349","author":"G Yu","year":"2025","unstructured":"Yu G, Wu X, Liu Z, Shi M, Fan H, Liu Y, Kuang N, Peng S, Lian Z, Huang C, Wu H, Fan B, Feng J, Cheng W, Sahakian BJ, Robbins TW, Becker B, Zhang J. Genetic influence and neural pathways underlying the dose-response relationships between wearable-measured physical activity and mental health in adolescence. Psychiatry Res. 2025;349:116503. https:\/\/doi.org\/10.1016\/j.psychres.2025.116503.","journal-title":"Psychiatry Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04962-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04962-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04962-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:51:17Z","timestamp":1782885077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04962-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4962"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04962-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics Committee of Beijing Tongren Hospital, Capital Medical University (Ethical Approval Number: TRECKY2021-179) and complied with the requirements of the Declaration of Helsinki. The study was conducted in accordance with the local legislation and institutional requirements. Given that this was a retrospective study without direct patient contact or sensitive issues, informed consent was not required in accordance with the guidelines of the Research Ethics Committee of Beijing Tongren Hospital, Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}